Jingying Wang is a seasoned professional in the field of clinical biomarker strategy and pharmacology, with extensive experience in cardiovascular and metabolic therapeutic areas. At Amgen, Jingying served as Sr. Scientist, Principal Scientist, and Associate Director in Clinical Biomarker for Precision Medicine, leading comprehensive clinical biomarker efforts from Phase 1 to Phase III. Prior experience includes roles at Children's Hospital Boston focusing on vascular biology and stem cell therapy, Johnson & Johnson in preclinical drug discovery, and Cytokinetics, where Jingying contributed to the pharmacology of cardiovascular programs. Jingying holds a Ph.D. in Pharmacology from the University at Buffalo and a BS in Pharmacy from Wuhan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices